CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2017
Cash flows from operating activities:
Net (loss) income	$ (79,520)	$ (45,375)	$ 31,813
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization	14,759	13,807	14,009
Stock-based compensation expense	10,526	10,258	8,159
Inventory impairments and abandonments	148,618	6,949	2,445
Deferred and other income tax (benefit) expense	(37,245)	93,935	678
Write-off of deposit on legacy land investment	0	0	2,700
Gain on sale of fixed assets	(232)	(351)	(294)
Change in allowance for doubtful accounts	(74)	48	(24)
Equity in income of unconsolidated entities	(403)	(127)	(401)
Cash distributions of income from unconsolidated entities	408	331	171
Loss on extinguishment of debt, net	24,920	27,839	12,630
Changes in operating assets and liabilities:
(Increase) decrease in accounts receivable	(1,674)	11,875	16,927
Decrease in income tax receivable	0	88	204
Decrease (increase) in inventory	42,927	(95,809)	41,911
Decrease (increase) in other assets	323	(1,300)	(168)
Increase (decrease) in trade accounts payable	4,720	17,492	(690)
(Decrease) increase in other liabilities	(14,418)	15,178	(25,208)
Net cash provided by operating activities	113,635	54,838	104,862
Cash flows from investing activities:
Capital expenditures	(21,356)	(17,020)	(12,440)
Proceeds from sale of fixed assets	251	370	297
Acquisition, net of cash acquired	(4,088)	(57,253)	0
Investments in unconsolidated entities	0	(421)	(3,261)
Return of capital from unconsolidated entities and marketable securities	68	176	1,621
Net cash used in investing activities	(25,125)	(74,148)	(13,783)
Cash flows from financing activities:
Repayment of debt	(576,548)	(522,465)	(274,436)
Proceeds from issuance of new debt	500,000	400,000	250,000
Repayment of borrowings from credit facility	(425,000)	(225,000)	(25,000)
Borrowings from credit facility	425,000	225,000	25,000
Debt issuance costs	(6,137)	(6,272)	(4,919)
Repurchase of common stock	(34,624)	0	0
Tax payments for stock-based compensation awards	(1,969)	(3,378)	(415)
Stock option exercises	314	64	24
Net cash used in financing activities	(118,964)	(132,051)	(29,746)
(Decrease) increase in cash, cash equivalents, and restricted cash	(30,454)	(151,361)	61,333
Cash, cash equivalents, and restricted cash at beginning of period	153,248	304,609	243,276
Cash, cash equivalents, and restricted cash at end of period	$ 122,794	$ 153,248	$ 304,609